1. Home
  2. MAIA vs GEOS Comparison

MAIA vs GEOS Comparison

Compare MAIA & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.01

Market Cap

69.2M

Sector

Health Care

ML Signal

SELL

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

SELL

Current Price

$3.41

Market Cap

61.4M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
MAIA
GEOS
Founded
2018
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
61.4M
IPO Year
2022
1997

Fundamental Metrics

Financial Performance
Metric
MAIA
GEOS
Price
$1.01
$3.41
Analyst Decision
Analyst Count
0
0
Target Price
★ $12.00
N/A
AVG Volume (30 Days)
★ 246.6K
87.5K
Earning Date
11-09-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.33
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $110,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.87
$3.41
52 Week High
$3.19
$24.01

Technical Indicators

Market Signals
Indicator
MAIA
GEOS
Relative Strength Index (RSI) 38.89 28.39
Support Level N/A N/A
Resistance Level $1.48 $4.80
Average True Range (ATR) 0.06 0.25
MACD -0.00 -0.04
Stochastic Oscillator 23.11 0.57

Price Performance

Historical Comparison
MAIA
GEOS

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

Share on Social Networks: